Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Dextromethorphan as an Augmentation Agent in Treatment-resistant Schizophrenia: A Randomized, Group Sequential Adaptive Design, Controlled Clinical Trial

NCT05944510 is registered in ClinicalTrials.gov with All India Institute of Medical Sciences, Bhubaneswar as lead sponsor.

NCT NCT05944510
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05944510 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Dextromethorphan as an Augmentation Agent in Treatment-resistant Schizophrenia: A Randomized, Group Sequential Adaptive Design, Controlled Clinical Trial
Lead sponsor
All India Institute of Medical Sciences, Bhubaneswar
Phase
Phase 4
Overall status
Completed
Start date
August 31, 2023
Completion date
April 30, 2025
Enrollment
40 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

treatment resistant schizophrenia